Front-line treatment of advanced non-small cell lung cancer with docetaxel and Gemcitabine: A multicenter phase II trial

被引：0
|
作者：
Georgoulias, V [1 ]
Kourousis, C [1 ]
Kakolyris, S [1 ]
Dimopoulos, MA [1 ]
Papadakis, E [1 ]
Apostolopulou, F [1 ]
Agelidou, A [1 ]
Tzianni, V [1 ]
Sarra, E [1 ]
Vardakis, N [1 ]
机构：
[1] Univ Gen Hosp Heraklion, Dept Med Oncol, Greek Cooperat Grp Lung Canc, Heraklion 71110, Crete, Greece
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
453
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [21] Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trial
    West, H. L.
    Wakelee, H. A.
    Perry, M. C.
    Belt, R. J.
    Chen, R.
    Obasaju, C.
    ANNALS OF ONCOLOGY, 2009, 20 (05) : 850 - 856
  • [22] Phase II trial of gemcitabine and cisplatin as first-line treatment of advanced non-small cell lung cancer (NSCLC).
    Lee, NS
    Byun, JH
    Bae, SB
    Kim, CK
    Lee, KT
    Park, SK
    Park, KK
    Won, JH
    Hong, DS
    Park, HS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 701S - 701S
  • [23] Gemcitabine as second-line treatment for relapsing or refractory advanced non-small cell lung cancer:: A phase II trial
    Crinò, L
    Mosconi, AM
    Scagliotti, GV
    Selvaggi, G
    Rinaldi, M
    Della Giulia, M
    Gridelli, C
    Calandri, C
    De Marinis, F
    Noseda, M
    Tonato, M
    SEMINARS IN ONCOLOGY, 1998, 25 (04) : 23 - 26
  • [24] A phase II of gemcitabine in advanced non-small cell lung cancer
    Koynov, K
    Tzekova, V
    Mincheva, N
    Scherer, A
    Krejcy, K
    3RD INTERNATIONAL CONGRESS ON LUNG CANCER, 1998, : 231 - 234
  • [25] Docetaxel plus cisplatin versus docetaxel plus gemcitabine chemotherapy in advanced non-small cell lung cancer: A preliminary analysis of a multicenter randomized phase II trial
    Georgoulias, V
    Papadakis, E
    Alexopoulos, A
    Stavrinidis, E
    Bania, E
    Rapti, A
    Grigoratou, T
    Kouroussis, C
    Kakolyris, S
    Samonis, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S249 - S249
  • [26] Multi-institutional phase II study of docetaxel (D) and gemcitabine (G) as front-line treatment of patients (pts) with advanced non-small-cell lung cancer (NSCLC).
    Amenedo, M
    Mel, JR
    Casal, J
    Rodriguez, MR
    Aparicio, LA
    Constenla, M
    Lopez, R
    Almanza, C
    Huarte, L
    ANNALS OF ONCOLOGY, 2000, 11 : 112 - 112
  • [27] Biweekly carboplatin and gemcitabine for untreated advanced non-small cell lung cancer (NSCLC). A multicenter phase II trial
    Domine, M
    Gomez, RG
    Firvida, J
    Delgado, J
    Estevez, L
    Docampo, LI
    Leon, A
    Pachon, V
    Casado, V
    Lobo, F
    LUNG CANCER, 2005, 49 : S242 - S242
  • [28] Docetaxel and gemcitabine combination as first-line treatment in advanced or metastatic non-small-cell lung cancer: A multicenter phase II study
    Costa, A
    Almodovar, T
    Seada, J
    Barata, F
    Teixeira, E
    Queiroga, H
    Pires, S
    PROCEEDINGS OF THE 9TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2004, : 117 - 120
  • [29] Docetaxel followed by gemcitabine in the treatment of advanced non-small cell lung cancer: A phase I study
    Frassineti, GL
    Ibrahim, T
    Zoli, W
    Monti, M
    Ricotti, L
    Nanni, O
    Amadori, D
    TUMORI JOURNAL, 2002, 88 (02): : 99 - 103
  • [30] Activity of gemcitabine and carboplatin in advanced non-small cell lung cancer: a phase II trial
    Masotti, A
    Zannini, G
    Gentile, A
    Morandini, G
    LUNG CANCER, 2002, 36 (01) : 99 - 103
12345